April 6, 2021
In vivo research with the highly contagious SARS-CoV-2 virus requires a specialized BSL-3 laboratory – defined by the Centers for Disease Control and Prevention as a lab with a biosafety level for working with microbes either indigenous or exotic that may cause “serious or potentially lethal disease through respiratory transmission.”
March 24, 2021
or the last several months, the employees of the UT Physicians Healthcare Transformation Initiatives (HTI) team have dedicated their nights and weekends to the vaccination effort.
March 22, 2021
When the opportunity was available to offer the COVID-19 vaccine to patients with disabilities on Saturday, Mar. 6, UT Physicians care providers worked together to offer a convenient drive-thru service at the vaccine hub of The University of Texas Health Science Center at Houston (UTHealth). UT Physicians is the clinical practice of McGovern Medical School at UTHealth.
March 19, 2021
Four months after launching the nation’s largest COVID-19 serological testing assessment, Texas CARES, researchers at The University of Texas Health Science Center at Houston (UTHealth) and the Texas Department of State Health Services (DSHS) have compiled preliminary data estimating that 14% to 24% of Texans have COVID-19 antibodies.
February 27, 2021
“You may be quick to compare Johnson & Johnson’s figures to those of previously authorized vaccines, such as Pfizer or Moderna, but a 66% percent efficacy rate of preventing symptomatic illness is worth celebrating,” said Katelyn Jetelina, PhD, an assistant professor at UTHealth School of Public Health in Dallas.